Botulinum-A toxin injection into the detrusor: A safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia

被引:129
作者
Riccabona, M
Koen, M
Schindler, M
Goedele, B
Pycha, A
Lusuardi, L
机构
[1] Krankenhaus Barmherzige Schwestern, Dept Pediat Urol, A-4010 Linz, Austria
[2] Gen Hosp Bozen, Dept Urol, Bolzano, Italy
关键词
bladder; meningocele; botulinum toxin type A; pediatrics;
D O I
10.1097/01.ju.0000108892.35041.2d
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We prospectively evaluated the efficacy and durability of botulinum-A toxin in the treatment of detrusor hyperreflexia in children with myelomeningocele (MMC). Materials and Methods: This study involved 15 patients with MMC (10 male and 5 female, mean age 5.8 years), all nonresponders to orally and intravesically administered anticholinergic medication and all on clean intermittent catheterization. Pretreatment assessment included a videourodynamic evaluation, an incontinence score and a mercaptoacetyltriglycine-3 renal scan. We injected 10 U/kg to a maximum of 360 U of botulinum-A toxin into the detrusor at 25 to 40 sites, sparing the trigone. Followup lasted between 12 and 30 months. All children underwent a urodynamic reevaluation, an assessment of the bladder capacity and an incontinence score at 3, 9 and 12 months after the first injection. A second intravesical injection was administered after 12 months and followup repeated as in the first year. Results: After the first injection treatment mean bladder reflex volume increased from 72.00 +/- 28.12 ml to 298 +/- 32.45 ml (mean +/- SD, p <0.001). Maximum detrusor pressure decreased from 78.76 +/- 23.14 cm H2O to 42.76 +/- 24.34 cm H2O (p <0.001). Maximum bladder capacity increased from 136.34 +/- 45.71 ml to 297.02 +/- 87.17 ml (p <0.001). Detrusor compliance increased from 18.29 +?- 27.19 ml/cm H2O to 51.17 +/- 38.17 ml/cm H2O (p <0.001). Of the 15 patients 13 became completely dry with CIC. The remaining 2 patients improved from score 3 to 1. Results after 9 months were similar to those obtained after 3 months. Mean durability of the effect of the drug was 10.5 months after the first as well as after the second intravesical injection. Conclusions: Botulinum-A toxin is a safe alternative in the management of detrusor hyperreflexia in children with MMC. The preliminary results regarding urodynamic parameters and continence have been promising.
引用
收藏
页码:845 / 848
页数:4
相关论文
共 19 条
[1]   STANDARDIZATION OF TERMINOLOGY OF LOWER URINARY-TRACT FUNCTION [J].
BATES, P ;
BRADLEY, WE ;
GLEN, E ;
GRIFFITHS, D ;
MELCHIOR, H ;
ROWAN, D ;
STERLING, A ;
ZINNER, N ;
HALD, T .
JOURNAL OF UROLOGY, 1979, 121 (05) :551-554
[2]   PREDICTIVE VALUE OF URODYNAMIC EVALUATION IN NEWBORNS WITH MYELODYSPLASIA [J].
BAUER, SB ;
HALLETT, M ;
KHOSHBIN, S ;
LEBOWITZ, RL ;
WINSTON, KR ;
GIBSON, S ;
COLODNY, AH ;
RETIK, AB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (05) :650-652
[3]   Botulinum toxin type A may improve bladder function in a rat chemical cystitis model [J].
Çayan, S ;
Coskun, B ;
Bozlu, M ;
Acar, D ;
Akbay, E ;
Ulusoy, E .
UROLOGICAL RESEARCH, 2003, 30 (06) :399-404
[4]  
Coffield J A, 1994, Trends Microbiol, V2, P67, DOI 10.1016/0966-842X(94)90532-0
[5]  
COFFIELD JA, 1994, THERAPY BOTULINUM TO
[6]  
COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P386
[7]  
DEPAIVA A, 1993, J BIOL CHEM, V268, P20838
[8]  
Drachman DB., 1971, NEUROPOISONS THEIR P, P325
[9]   EFFECTS OF BOTULINUM A TOXIN ON DETRUSOR-SPHINCTER DYSSYNERGIA IN SPINAL-CORD INJURY PATIENTS [J].
DYKSTRA, DD ;
SIDI, AA ;
SCOTT, AB ;
PAGEL, JM ;
GOLDISH, GD .
JOURNAL OF UROLOGY, 1988, 139 (05) :919-922
[10]   NONSURGICAL MANAGEMENT OF THREATENED UPPER URINARY TRACTS AND INCONTINENCE IN CHILDREN WITH MYELOMENINGOCELE [J].
HERNANDEZ, RD ;
HURWITZ, RS ;
FOOTE, JE ;
ZIMMERN, PE ;
LEACH, GE .
JOURNAL OF UROLOGY, 1994, 152 (05) :1582-1585